Alex Long
Amgen (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Cancer-related Molecular Pathways, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Cancer Mechanisms and Therapy
Most-Cited Works
- → Structure-Based Design of Potent and Selective CK1γ Inhibitors(2012)21 cited
- Discovery of a potent, highly selective Tie-2 kinase inhibitor demonstrating in vivo efficacy, based on a novel pyridyl triazine scaffold.(2006)